Health Science University
Istanbul, 34668, Turkey (Türkiye)
NCT Number: NCT06954506
This quasi-experimental study aims to examine the effect of Reiki on the level of hopelessness in oncology patients.
The study was conducted at İzmir Tepecik Training and Research Hospital with 32 patients in both experimental and control groups. Patients performed Reiki daily for a week following each chemotherapy session for 4 cycles. Data were collected using the "Individual Information Form" and the "Beck Hopelessness Scale" through face-to-face and telephone interviews. Ethical approval was obtained, and data were analyzed using SPSS.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Istanbul, 34668, Turkey (Türkiye)
Reiki is considered a complementary and alternative therapy method that can be effective in coping with such emotional challenges and enhancing psychological well-being. It is thought that Reiki practices, by regulating the flow of energy and providing deep relaxation, can reduce individuals' levels of hopelessness and improve overall quality of life. This study will investigate the effect of Reiki practices on the levels of hopelessness in oncology patients.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Receiving treatment at the Outpatient Chemotherapy Unit of İzmir Tepecik Training and Research Hospital University of Health Sciences, Diagnosed with cancer, Aged 18 and over, Willing to participate in the research
Exclusion criteria
Not willing to participate in the research, Having communication problems
Patients were informed about the application, and a Reiki application video prepared/selected by the researchers was shared with the patients. Patients were asked to perform Reiki every day for a week following each chemotherapy session for 4 cycles. A reminder message was sent to the patients the day before each cycle for the Reiki application. The level of hopelessness was reassessed at the end of each week.
Time frame: The research data were collected through face-to-face and telephone interviews after obtaining ethical committee approval. The time required for individuals to complete the forms is approximately 10 minutes.
Individual Information Form: The form prepared by the researchers consists of 14 questions.
Beck Hopelessness Scale: The Beck Hopelessness Scale was developed by Beck and colleagues in 1974 to determine the degree of pessimism an individual has about the future. The scale consists of 20 items in a five-point Likert format. The questions are answered as true or false and reflect negative expectations. Each answer that matches the given key scores 1 point, while answers that do not match score 0 points. The total score obtained is considered the "hopelessness" score, with higher scores indicating higher levels of hopelessness. The scale's score range is 0-20. The questions on the scale cover emotional, motivational, and cognitive dimensions. The scale consists of three factors: "Feelings about the Future," "Loss of Motivation," and "Future Expectations" (Durak & Palabıyıkoğlu, 1994). In this study, the Cronbach's Alpha value for hopelessness was calculated as 0.952.
Saglik Bilimleri Universitesi
Other
The Effect of Reiki on Hopelessness Level in Oncology Patients Receiving Chemotherapy Treatment; Randomised Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01231347
Adenocarcinoma of the Pancreas, Advanced Malignancy
Fullerton, California, United States
View Trial DetailsNCT01444404
Advanced Malignancy, Advanced Solid Tumors
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT01253707
Advanced Malignancy, Advanced Solid Tumors
Los Angeles, California, United States
View Trial DetailsNCT01723020
Advanced Malignancy, Advanced Solid Tumors
Santa Monica, California, United States
View Trial Details